FreeGuest Editorial FDA e-cigarette flavoring ban leaves a bad taste“Trump eroding role of science in government” January 03, 2020Vol.46 No.01By Alan Blum
Drugs & TargetsFree FDA issues draft guidance to foster pediatric oncology product development December 13, 2019Vol.45 No.46
Drugs & TargetsFree FDA approves Avsola for same indications as Remicade December 13, 2019Vol.45 No.46
Drugs & TargetsFree FDA grants Janssen’s BCMA CAR-T therapy JNJ-4528 Breakthrough Therapy Designation for multiple myeloma indication December 13, 2019Vol.45 No.46
Clinical RoundupFree PD-1 inhibitor treatment prior to stem cell transplant is safe, effective in classic Hodgkin lymphoma December 13, 2019Vol.45 No.46
Clinical RoundupFree BMS’s liso-cel met primary, secondary endpoints in TRANSCEND NHL 001 December 13, 2019Vol.45 No.46
Clinical RoundupFree Phase II KarMMa study of ide-cel in relapsed, refractory multiple myeloma meets ORR primary endpoint December 13, 2019Vol.45 No.46
Clinical RoundupFree Seattle Genetics announces positive OS, PFS, ORR for tucatinib in HER2+ breast cancer December 13, 2019Vol.45 No.46
Clinical RoundupFree ctDNA may help predict recurrence in patient with early triple-negative breast cancer December 13, 2019Vol.45 No.46
Clinical RoundupFree Extended follow-up phase III data underscore sustained efficacy and safety of Imbruvica in CLL December 13, 2019Vol.45 No.46
